Table 2 Clinical outcomes after propensity score (PS) matching
Outcomes | COVID-19 alone | COVID-19 co-infected with other respiratory viruses | P-value | Hazard ratio (HR) (95%CI) | P-value $ |
|---|---|---|---|---|---|
30-day mortality, n (%)∆ | 19 (73.1) | 4 (44.4) | 0.12** | 0.39 (0.13, 1.20) | 0.10 |
In-hospital mortality, n (%)∆ | 20 (76.9) | 4 (44.4) | 0.07** | 0.32 (0.10, 0.97) | 0.04 |
| Â | Â | Â | Â | Beta coefficient (Estimates) (95%CI) | P-value $* |
|---|---|---|---|---|---|
MV duration (days), median (Q1,Q3) ∆ | 12.0 (4.00, 20.00) | 23.0 (18.00, 35.00) | 0.01^ | 0.55 (0.04,1.06) | 0.03 |
ICU Length of stay (days), median (Q1, Q3) ∆ | 16.5 (11.50, 21.50) | 23.0 (15.00, 40.00) | 0.04^ | 0.34 (− 0.02, 0.69) | 0.06 |
Hospital length of stay (days), median (Q1, Q3) ∆ | 22.5 (14.00, 32.50) | 31.0 (23.00, 53.00) | 0.05^ | 0.52 (0.05, 1.00) | 0.03 |